Introduction
Innovations are continuously being made in bone tissue engineering, from implanted material to bone substitutes, and subsequently autologous bone grafting (1) (2) (3) (4) , which avoids the issue of graft rejection; however, it has not solved the problem of limited endogenous supply, prolonged surgical duration and harvest complications (5) (6) (7) . Cell sources, such as bone marrow mesenchymal stem cells and adipose-derived stem cells have generated significant interest for their tissue engineering potential (8, 9) . Perivascular stem cells (PSCs) are a homogeneous mesenchymal stem cell (MSC) population purified by fluorescence activated cell sorting (FACS). PSCs are cell populations that are comprised of pericytes [cluster of differentiation (CD)45 -CD34 -CD146 + ) (10) and adventitial cells (CD45 -CD34 + CD146 -), which are selected by f luorescence-activated cell sorting (FACS) (11) . The histological localization is in blood vessels, and the two cell types have been reported to possess characteristics of mesenchymal stem cells (MSCs) (12) (13) (14) . PSCs are the natural ancestors of MSCs, and are responsible for homeostasis and repair in vivo. Previous studies have indicated that purified PSCs have increased chondrogenic potential when compared with conventional MSCs derived in culture (10, 15) . Lipoaspirate-derived human PSCs have demonstrated myogenic and angiogenic potential, and have exhibited a strong therapeutic effect in the treatment of rotator cuff tears (16) . PSC xenografting demonstrated the osteogenic capability of this cell type in ectopic and orthotopic bone regeneration models (17) . Additionally, a study indicated that osteoinductive growth factor Nel-like molecule 1 induced human (h) PSC osteogenesis (18) . hPSCs may present as a promising cell source for future efforts in skeletal regenerative medicine. hPSCs provide a stem cell-based therapeutic modality that is readily approved by the United States Food and Drug Administration, with potentially increased safety, purity, identity, potency and efficacy (19) . PSCs are abundant in human white adipose tissue (20) ; thus, adipose tissue is an ideal MSC source, as it is dispensable and accessible with minimal morbidity. Therefore, in recent years, numerous studies describing the identification, isolation and characterization of PSCs from the adipose tissues of humans and animals have been performed (9, 11, (20) (21) (22) . However, at present, to the best of our knowledge, there are no studies on the purification and identification of PSCs in minipigs (mps). Therefore, it is hypothesized that there is a phenotype similar to that of the human body in mpPSCs. The findings may benefit cosmetic dentistry and facial cosmetic surgery fields, as the orthodontic tooth or craniofacial bone tissue repair are closely associated with the development of bone. The aim of the current study was to identify, isolate and characterize PSCs from mp adipose tissue samples (n=9). Purification of mpPSCs by FACS (which is used in human PSC purification), and investigation of mpPSC osteogenic and adipogenic potential (using Alizarin Red S staining and Oil Red O staining in vitro, respectively) was performed, followed by observing the cell morphometry after cell isolation and culture. In addition, hematoxylin and eosin (H&E) staining was conducted to identify the fat tissue structure and vascular distribution. Furthermore, osteogenic induction differentiation regulating genes, osteocalcin (OCN) and collagen, type I, α1 (COL1A1), and the adipogenesis-associated gene, peroxisome proliferator-activated receptor-γ (PPARG) (23) were evaluated by reverse transcription-quantitative polymerase chain reaction (RT-qPCR).
Materials and methods
PSC identification, isolation and culture. hPSCs were provided by liposuction patients (anonymous) following surgery at the Beijing Huangsi Cosmetic Plastic Surgery Hospital (Beijing, China). The mp adipose tissue samples were obtained from 9 male, health-certified Guizhou mps (age, 10 months; mean weight, 37 kg) from the Chinese Academy of Agricultural Sciences (Beijing, China). All protocols were approved by the Animal Use and Care Committee of Peking University (Beijing, China; permit no. LA2014216). Unless otherwise stated, the subcutaneous fat from the posterior neck of the mps was used.
In order to determine the minipig stromal vascular fraction (SVF) yield, H&E staining was performed on tissue sections (~1x1x0.5 cm ). The mp adipose tissue samples were snap frozen and cryosections were obtained at -30˚C, then the tissue samples were stained with H&E according to the following protocol: Tissue samples were fixed using formalin for 24 h, regularly dehydrated and routinely embedded. The sections were deparaffinized and rehydrated with xylene, 100% alcohol, 95% alcohol, 75% alcohol. The sections were stained in Harris hematoxylin solution at room temperature for 10 min, differentiated with 1% acid alcohol for 3-5 sec until the nucleus was colored blue, then counterstained in eosin Y solution for 30 sec, dehydrated with 95 then 100% alcohol, rehydrated with xylene and mounted using neutral balsam. Images were captured using an Olympus BX60 microscope (Olympus Corp., Tokyo, Hapan) using a x40 objective oil immersion lens. Subsequently, the PSCs were analyzed and isolated from the minipig adipose tissues via flow cytometry. Isolation and culture were performed as previously described for hPSC isolation (14, 20) .
Lipoaspirate specimens were enzymatically digested to obtain the SVF. The SVF was incubated at 37˚C for 50 min with antibodies recognizing human PSC antibodies and mp PSC antibodies. Mp PSC antibodies were as follows: CD146-f luorescein isothiocyanate (FITC; 1:100; cat. no. MCA2141F; Bio-Rad Laboratories, Inc., Hercules, CA, USA), CD45-phycoerythrin (PE; 1:100; cat. no. SM563R; OriGene Technologies, Inc., Rockville, MD, USA) and CD34 (1:100; cat. no. ab81289; Abcam, Cambridge, MA, USA). Human PSC antibodies were as follows: CD146-PE (1:100; cat. no. 55305), CD45-FITC (1:100; cat. no. 555482) and CD34-APC (1:100; cat. no. 555824) (BD, Hercules, CA, USA). Cells were sorted using a special order five-laser BD FACS Aria Ⅲ high-speed cell sorter (BD Biosciences, Franklin Lakes, NJ, USA -pericytes were purified using FACS and cultured until passages four to six in a monolayer culture.
In vitro osteogenic differentiation assays. For osteogenic differentiation, cells were seeded into 24-well plates at a density of 5x10 4 cells/well. Following attachment, cells were treated with osteogenic differentiation medium (ODM) consisting of DMEM, 10% FBS, 10 mM β-glycerophosphate and 50 µM ascorbic acid. In select studies, ODM was supplemented with 1 µM dexamethasone (Sigma-Aldrich; Merck KGaA, Darmstadt; cat. no. D4902-25MG). The medium was refreshed every three days. After 14 days, osteogenic differentiation was assessed using Alizarin Red S staining according to the manufacturer's protocol (cat. no. 0223; ScienCell Research Laboratories, Inc., San Diego, CA, USA). Briefly, cells were seeded at a density of 5x10 4 cells/well in 24-well plates. Cells were subsequently fixed for 15 min at 5˚C in 4% paraformaldehyde prior to staining with 2% Alizarin Red S for 10 min at room temperature. Cetylpyridinium chloride (10%; Sigma-Aldrich; Merck KGaA) was subsequently applied for 15 min at room temperature for quantification. Cells were examined under an inverted fluorescence microscope (magnification, x200) and quantification was performed with a microplate spectrophotometer at 562 nm.
In vitro adipogenic dif ferentiation assays. A fter 14 days of differentiation, the cells were washed gently with phosphate-buffered saline (PBS) and fixed with 4% paraformaldehyde (pH 7.4) for 10 min. The fixed liquid was discarded. Lipid droplets were stained with 0.5% Oil Red O in 60% isopropanol at room temperature for 15 min. The Oil Red O was removed and the plates were rinsed with water and dried at 37˚C. Subsequently, 60% isopropanol was used to extract the dye from the cells for 10-20 min, and the cells were washed with PBS twice, at last immersed in PBS and observed under an inverted light microscope (magnification, x200).
RT-qPCR. Total RNAs were extracted from the lung tissue samples of each group. cDNA was synthesized using a TaqMan™ MicroRNA reverse transcription kit (cat. no. 4366596; Thermo Fisher Scientific, Inc.) and cDNA served as a template for RT-qPCR (Applied Biosystems 7500 Real-Time PCR Instrument; Thermo Fisher Scientific, Inc.). Reactions were conducted in 96-well optical plates at 95˚C for 10 min, followed by 40 cycles at 95˚C for 15 sec and 60˚C for 1 min. The quantification cycle (Cq) data were determined using default threshold settings (24) . The Cc was defined as the fractional cycle number at which the fluorescence passes the fixed threshold. Reactions were run in duplicate to triplicate per RNA isolate. The relative expression of OCN, COL1A1 and PPARG in each group of cells were calculated by RT-qPCR and GAPDH served as an internal standard. Primer sequences were as follows: GAPDH forward, CAA TGA CCC CTT CAT TGA CC and reverse, GAA GAT GGT GAT GGC CTT TC; COL1A1 forward, GGT TTC AGT GGT TTG GAT GG and reverse, TCC ATT TTC ACC AGG GCT AC; OCN forward, TCA CAC TGC TTG CCC TAC TG and reverse, CTG CAC CTT TGC CAG AAT C; and PPARG forward, GCC AAG GAT TCA TGA CAA GG and reverse, TTG GGC TCC ATA AAG TCA CC.
Statistical analysis. All results were expressed as means ± standard error and analyzed using SPSS version 19 (IBM Corp., Armonk, NY, USA). The difference was detected by Student t-test, or one-way analysis of variance followed by Fisher's Least Significant Difference post-hoc test for different group data analysis and P<0.05 was considered to indicate a statistically significant difference.
Results

mpPSCs and hPSCs are obtained by identical processes.
Previous studies have optimized the procedure for obtaining hPSCs (8) . In the current study, two subgroups of hPSCs, the CD45 -CD34 -CD146 + phenotype of perithelial cells (P4) and the CD45 -CD34 + CD146 -phenotype of adventitial cells (P5), were isolated from human liposuction fat by FACS (Fig. 1) . Subsequently, this protocol was applied to mp adipose tissue samples. Single cells were gated and histograms of each antibody were compared with the relevant isotype control (Fig. 2) . Cells were sorted into CD45 -CD34 -CD146 + (P4) and CD45
-CD34 + CD146 -cell populations (P5). The two -cell populations accounted for 1.4% (P4/P1) and 7.2% (P5/P1) of SVF cells, respectively, with a total of 8.6%, which was lower than that previously reported in the literature (9) . In the current study, immunohistochemistry was not performed; therefore, the hPSC phenotypes of the cells corresponding to that of the mps were used as the supporting evidence to consider these two cell populations as 'PSCs' (mpPSCs).
SVF are abundant in mp white adipose tissue. In order to determine the SVF content in mp adipose tissue, H&E staining was performed in subcutaneous adipose tissue sampled from the posterior neck of the mps. As shown in Fig. 3 , it was observed at low magnification that adipose tissue was predominantly composed of a large number of vacuolar fatty cells and a small quantity of connective tissue. Observation of connective tissue at high magnification demonstrated abundant vascular-like structures, with diameters from several microns to hundreds of microns. The vascular wall exhibited three layers of arteriovenous-like structures (endometrium, intermediate muscle layer and outer membrane) and capillary-like monolayer structures (predominantly including the endothelial layer and the surrounding cells). This region of the structure was termed SVF, and according to the human PSC theory, the fat derived mpPSCs are separate from this region.
Cell morphology of the mpPSCs. The morphology of the cells adhered to the wall are presented in Fig. 4 . Following cell sorting, the cells were separated and then mixed in culture. The result indicated that the morphology of the two groups of cells that had adhered to the wall was marginally different. The cell morphology of the CD45 -CD34 -CD146 + group was longer and narrower, and the cell morphology of the CD45 -CD34 + CD146
group was polygonal.
mpPSCs demonstrated MSC characteristics. mpPSCs were evaluated based on their adipogenic and osteoplastic differentiation ability. As presented in Fig. 5 , typical staining of calcium nodules was demonstrated by Alizarin Red in the two groups. There was a wider area of deeper staining in the group of PSCs, indicating that mpPSCs had a stronger and more prevalent ability in calcium nodule formation than pSVFs, which indicated that the mpPSCs were able to undergo osteoplastic differentiation. The ability of adipogenic differentiation was detected by the results of Oil Red O staining (Fig. 6) . The results demonstrated the presence of lipid droplets, with grape-like clusters observed in in the two groups. The lipid droplet density of the mpPSCs group was significantly higher than that of the pSVF group, indicating that the lipid composition ability of the mpPSCs was stronger.
O s t e o g e n i c i n d u c t i o n d i f f e r e n t i a t i o n a n d adipogenesis-associated gene expression levels were higher in the mpPSCs group than in the pSVF group.
The results of the RT-qPCR (Fig. 7) demonstrate that compared with the pSVF group, the mRNA expression levels of osteogenic induction differentiation regulating genes, OCN and COL1A1, and adipogenesis-associated gene, PPARG in the mpPSCs group were significantly higher (P<0.05). 
Discussion
The current study investigated mps as a novel source of PSCs for translational effects in bone tissue engineering. The data revealed that mpPSCs could be isolated from SVF with an identical isolation protocol to hPSCs. The present study further confirmed the characteristics of mpPSCs, including the morphology of the cells that adhered to the wall, and their adipogenic and osteoplastic differentiation ability using Alizarin Red and Oil Red O staining, the result demonstrated that mpPSCs exhibited the following characteristics of stem cells: Adherent growth, clonal formation, multipotent differentiation-osteogenesis and adipogenic. Additionally, adipogenesis-associated gene expression was measured using RT-qPCR, and the result demonstrated that compared with the pSVF group, the expression levels of OCN, COL1A1 and PPARG mRNA in the mpPSC group was significantly higher (P<0.05). The H&E staining performed in the subcutaneous adipose tissue of the posterior neck of the mps indicated that there was abundant SVF in mps. These data confirm the possibility that mps provide a source of PSCs. The possible novel source of PSCs identified during the current study, which may supplement currently confirmed sources, as described in different species, including humans (9,10), canines (22) , sheep (25) and mice (26) . Notably, the same markers were used to identify PSCs in these different species, using, in the majority of instances, cross-reactive antibodies. This indicates a highly-conserved set of perivascular markers for an ancestral population of tissue regenerative cells.
Adipose tissue is an attractive source of PSCs, as it is dispensable and accessible with minimal associated morbidity (27, 28) , PSCs consist of pericytes and adventitial cells; pericytes are a type of cell that typically reside around smaller blood vessels, including capillaries, venules and arterioles, whereas adventitial cells are located around larger arteries and veins (10, 29) . PSCs have demonstrated osteogenic, chondrogenic, adipogenic, and myogenic potential, indicating the potential for multiple applications in skeletal regenerative medicine without culture expansion (9, 11, 19, 22, 27, 30) . mps are a type of easily cultured animal. The observation that CD146 and CD34 have a perivascular location in mp tissues, which coincides with that of established MSC markers is consistent with the characteristic of pericytes and adventitial cells of PSCs described in previous reports (22, 31) . The current result further confirmed the perivascular location of MSCs in mps, as demonstrated by H&E staining, which has already been described in humans and other animals (22, 25, 30, 31) .
The cell can only be defined as PSCs if it satisfies the following conditions: Located in the vascular wall and exhibiting stem cell characteristics (22, 24 In addition, the results of flow cytometry indicated that compared with man, the cell rate of PSC-like cells from mps was lower, due to various potential reasons: Firstly, in the current study, the indirect CD34 antibody marker was used, not the mp antibody, which may have affected the identification of cell surface molecules; additionally, the CD146-FITC antibody used in the present study was a human monoclonal antibody, which worked in the mp tissues, but with less antibody specificity than in human cells; so CD34 and CD146 may not identify adventitial cells and pericytes specifically; finally, blood vessel density in mp fat may be lower than that of human fat. The cell sorting was not obvious in flow cytometry, which also supported the inference of poor antibody specificity. Therefore, it would be prudent to state that the cells involved in the current experiment are termed mp CD45 -CD34 -CD146 + and CD45 -CD34 + CD146 -progenitors. In conclusion, the H&E staining results and the characteristics of stem cells after sorting indirectly support the existence of vascular stem cells in the fat of mps. In vitro experiments demonstrate that the adipogenic differentiation potential of mp vascular stem cells was significantly stronger than that of non-selected vascular stromal cells. These results lay the foundation for the future isolation and characterization of CD146 + and CD34 + cell subpopulations from mp adipose tissues.
